The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats.
- DOI
- 10.1016/j.ebiom.2025.105862
- Published
- 2025-07-23
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2025.105862,
title = {The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats.},
author = {Kuhre RE and Ballarín-González B and Brand CL and Glendorf T and Madsen KG and Hjøllund KR and Hogendorf WFJ and Ipsen DH and Lundh S and Kruse T and Petersen SB and Secher A and Vegge A and Raun K.},
year = {2025},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2025.105862},
url = {https://doi.org/10.1016/j.ebiom.2025.105862}
}RIS
TY - JOUR TI - The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats. AU - Kuhre RE AU - Ballarín-González B AU - Brand CL AU - Glendorf T AU - Madsen KG AU - Hjøllund KR AU - Hogendorf WFJ AU - Ipsen DH AU - Lundh S AU - Kruse T AU - Petersen SB AU - Secher A AU - Vegge A AU - Raun K. PY - 2025 JO - EBioMedicine DO - 10.1016/j.ebiom.2025.105862 UR - https://doi.org/10.1016/j.ebiom.2025.105862 ER -
APA
RE, K., B, B., CL, B., T, G., KG, M., KR, H., WFJ, H., DH, I., S, L., T, K., SB, P., A, S., A, V., & K., R. (2025). The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2025.105862
Source records
- europe-pmc · retrieved 2026-09-26T01:42:35.550Z
- doaj · retrieved 2026-09-26T01:42:35.598Z